Phase I, II, I/II, and III studies' forms are available on-line. Please contact Randomization at (215) 574-3191 to request other forms packets.
The following studies' forms are now available in PDF (Adobe Acrobat) format:

1. 0926 Phase II Bladder
2. 0921 Phase II Endometrial
3. 0920 Phase III Post-Op Advanced H & N
4. 0915 Phase II SBRT
5. 0848 Phase III Pancreas
6. 0841 Screening for Depression
7. 0837 Phase II GBM
8. 0831 Phase III Tadalafil/Placebo Prostate
9. 0825 Phase III GBM
10. 0822 Phase II Rectal
11. 0815 Phase III Prostate
12. 0813 Phase I/II SBRT
13. 0724 Phase III Cervix
14. 0712 Phase II Bladder
15. 0631 Phase II/III Spine Mets
16. 0630 Phase II Sarcoma
17. 0627 Phase II GBM
18. 0625 Phase II GBM
19. 0623 Phase II SCLC
20. 0622 Phase II Prostate Samarium
21. 0621 Phase II Prostate
22. 0619 Phase II High-Risk Post-Op H & N
23. 0618 Phase II SBRT
24. 0617 Phase III NSCLC
25. 0615 Phase II Nasopharyngeal
26. 0614 Phase III Memantine/Placebo/WBRT
27. 0611 GBM VEGF/MMP
28. 0539 Phase II Meningioma
29. 0537 Phase II/III Electroacustimulation/Pilocarpine
30. 0534 Phase III Prostate
31. 0529 Phase II Anal Canal
32. 0526 Phase II Prostate Brachy
33. 0525 Phase III GBM
34. 0524 Chemo/XRT for Non-cystectomy Bladder Cancer
35. 0522 Advanced H & N
36. 0521 Phase III study of Localized High Risk Prostate Cancer
37. 0518 Phase III Prevent Osteo
38. 0517 Palliation Bone Mets
39. 0515 NSCLC
40. 0514 Head and Neck Tissue/Specimen Bank
41. 0513 Phase I/II GBM
42. 0438 Phase I RT Unresectable Liver Mets
43. 0436 Phase III Esophagus
44. 0435 H & N/Palifermin
45. 0424 Phase II Brain Chemoradiation for High Risk Low Grade Glioma
46. 0421 Phase III Recurrent Head and Neck
47. 0420 Phase II GBM RT & TMZ Followed by TMZ & Irinotecan
48. 0418 Phase II IMRT
49. 0417 Phase II Cervix/Bevacizumab
50. 0415 Phase III Prostate
51. 0412 Phase III Lung
52. 0411 Phase II Advanced Pancreas
53. 0330 Phase II Sarcoma
54. 0324 Phase II Lung: Cetuximab with Chemoradiation
55. 0321 Phase II Prostate Cancer
56. 0320 Phase III Multiple Brain Metastases
57. 0319 Phase I/II Breast 3D CRT
58. 0315 Phase III Sandostatin
59. 0247 Phase II Rectal
60. 0246 Phase II Esophagus
61. 0244 Head & Neck Phase II Salivary
62. 0241 Phase I Lung
63. 0239 Phase II Lung
64. 0236 Inoperable Stage I/II NSCLC
65. 0234 Phase II
66. 0233 Bladder/Chemotherapy + RT
67. 0232 Phase III Prostate
68. 0229 Phase II Lung
69. 0227 Phase I/II CNS Lymphoma
70. 0225 Phase II Nasopharyngeal IMRT/Chemotherapy
71. 0215 Prostate
72. 0214 Lung Prophylactic Cranial RT
73. 0213 Phase I/II Lung
74. 0212 Lung Prophylactic Cranial RT
75. 0211 GBM - RT & Iressa (ZD1839)
76. 0132 Gleevec (STI-571)/Gist
77. 0131 Pre-Irradiation & Concurrent Temozolomide Anaplastic Oligodendrogliomas & Mixed Anaplastic Oligoastrocytomas
78. H-0129 Head and Neck
79. 0128 Phase II Cervix: RT + Chemotherapy, (+) Celebrex
80. P-0126 Prostate
81. 0124 Retroperitoneal Sarcoma
82. 0123 Phase II Lung
83. 0122 Cancer Cachexia
84. 0119 Phase II Melatonin for Brain Metastasis
85. BR-0118 Multiple Brain Metastases
86. 0117 Phase I/II Lung: 3D-CRT/Chemo
87. 0116 Phase I/II Cervix: RT + Chemotherapy
88. 0114 GastricPost-Op Chemo/RT
89. 0113 Phase II Esophagus / Chemoradiotherapy
90. 0024 Phase II Post-Op Head & Neck
91. 0023 GBM-EBXRT & SRT
92. 0022 Phase I/II Head and Neck IMRT
93. 0020 Locally Advanced Pancreas
94. 0019 Phase II Prostate Implant
95. 0017 Phase I Lung
96. P-0014 Prostate
97. 0013 Phase II GBM/Bleomycin
98. 0012 Phase II Rectal Study
99. P-0011 Prostate
100. 9914 Adv. Head and Neck
101. 9913 Head and Neck
102. 9911 Recurrent Head & Neck
103. 9910 Prostate
104. 9909 Post Op Immunotherapy/RT
105. 9905 Endometrium
106. 9904 Gastric
107. 9903 Head and Neck
108. 9902 Prostate
109. 9901 Head and Neck
110. 9813 Anaplastic Astrocytoma
111. 9811 Anal Canal
112. 9809 GI Sequelae/PPS
113. 9804 Breast DCIS
114. 9803 Phase I/II 3D GBM
115. 9802 Low Grade Glioma
116. 9801 Lung/Amifostine
117. 9712 Phase I Lung: Chemo/RT LSCLC
118. 9714 Bone Metastases
119. 9704 Pancreas
120. 9703 Advanced H & N
121. 9601 Prostatectomy
122. 9517 Breast Brachytherapy
123. 9514 Sarcoma
124. 9512 T2 Vocal Cord
125. 9501 Post-Op
126. 9413 Phase III Prostate
127. 9408 Phase III Prostate
128. 9406 Prostate 3D-CRT
129. 9202 Phase III Prostate
130. 9111 Larynx
131. 9003 Multi/FX
132. 8531 Phase III Prostate

The following non-study specific forms are available:

Miscellaneous

1. Adverse Event Expedited Reporting System (AdEERS)
2. FDA Form 1572 - Statement of Investigator [PDF]
3. General Communication Memo [PDF]
4. Label Request [PDF]
5. Request for Change in Primary Research Associate [PDF]
6. Patient Transfer Form [DOC]
7. Intergroup Case Credit Form [PDF]
8. Calendar Request [PDF]
9. Pill Diary Template [PDF]

Pathology

1. Specimen Transmittal Form [PDF]

Regulatory

1. 310 Form for IRB approvals. [PDF]

Withdrawal of Consent

1. CW Instructions [PDF]
2. CW Form [PDF]
3. CQ Instructions [PDF]
4. CQ Form [PDF]

International Site Participation

1. Exhibit D - Logistical Issues & Letter of Intent [doc]
2. International REC Certification [doc]